Kevin M. Allan

884 total citations
11 papers, 772 citations indexed

About

Kevin M. Allan is a scholar working on Organic Chemistry, Cancer Research and Molecular Biology. According to data from OpenAlex, Kevin M. Allan has authored 11 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Kevin M. Allan's work include Cyclization and Aryne Chemistry (6 papers), Chemical synthesis and alkaloids (4 papers) and Synthesis and Biological Activity (3 papers). Kevin M. Allan is often cited by papers focused on Cyclization and Aryne Chemistry (6 papers), Chemical synthesis and alkaloids (4 papers) and Synthesis and Biological Activity (3 papers). Kevin M. Allan collaborates with scholars based in United States. Kevin M. Allan's co-authors include Brian M. Stoltz, Christopher D. Gilmore, Viresh H. Rawal, Vikram Bhat, Kenichi Kobayashi, Pamela M. Tadross, Kenji Negoro, Guillaume Lapointe, Dennis J. Slamon and Scott C. Virgil and has published in prestigious journals such as Science, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Kevin M. Allan

11 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin M. Allan United States 9 698 74 73 65 64 11 772
Christopher D. Gilmore United States 6 557 0.8× 76 1.0× 18 0.2× 33 0.5× 44 0.7× 7 587
Vikram C. Purohit United States 11 636 0.9× 43 0.6× 19 0.3× 25 0.4× 130 2.0× 15 739
John E. Mills United States 10 318 0.5× 23 0.3× 20 0.3× 63 1.0× 118 1.8× 21 417
C. B. W. Senanayake United States 12 546 0.8× 8 0.1× 37 0.5× 64 1.0× 118 1.8× 15 590
Agnès Pommier France 11 427 0.6× 11 0.1× 17 0.2× 43 0.7× 106 1.7× 12 494
Christine E. Brotherton United States 10 409 0.6× 20 0.3× 24 0.3× 59 0.9× 45 0.7× 13 432
Masatoshi Murakata Japan 14 514 0.7× 10 0.1× 16 0.2× 29 0.4× 131 2.0× 31 586
Mali V. Reddy United States 11 627 0.9× 7 0.1× 51 0.7× 83 1.3× 139 2.2× 11 706
Keisuke Kakiguchi Japan 9 348 0.5× 17 0.2× 12 0.2× 63 1.0× 48 0.8× 9 384
D. Sivakumar Reddy India 9 267 0.4× 29 0.4× 24 0.3× 19 0.3× 89 1.4× 9 323

Countries citing papers authored by Kevin M. Allan

Since Specialization
Citations

This map shows the geographic impact of Kevin M. Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin M. Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin M. Allan more than expected).

Fields of papers citing papers by Kevin M. Allan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin M. Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin M. Allan. The network helps show where Kevin M. Allan may publish in the future.

Co-authorship network of co-authors of Kevin M. Allan

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin M. Allan. A scholar is included among the top collaborators of Kevin M. Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin M. Allan. Kevin M. Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Welin, Eric R., Aurapat Ngamnithiporn, Guillaume Lapointe, et al.. (2018). Concise total syntheses of (–)-jorunnamycin A and (–)-jorumycin enabled by asymmetric catalysis. Science. 363(6424). 270–275. 94 indexed citations
2.
Crawford, Jeffrey D., Kevin M. Allan, Kyle D. Hart, et al.. (2015). The Natural History of Indeterminate Blunt Cerebrovascular Injury. JAMA Surgery. 150(9). 841–841. 27 indexed citations
3.
4.
Allan, Kevin M., Christopher D. Gilmore, & Brian M. Stoltz. (2011). Benzannulated Bicycles by Three‐Component Aryne Reactions. Angewandte Chemie International Edition. 50(19). 4488–4491. 113 indexed citations
5.
Allan, Kevin M., Christopher D. Gilmore, & Brian M. Stoltz. (2011). Benzannulated Bicycles by Three‐Component Aryne Reactions. Angewandte Chemie. 123(19). 4580–4583. 28 indexed citations
6.
Bhat, Vikram, Kevin M. Allan, & Viresh H. Rawal. (2011). Total Synthesis ofN-Methylwelwitindolinone D Isonitrile. Journal of the American Chemical Society. 133(15). 5798–5801. 89 indexed citations
7.
Allan, Kevin M., et al.. (2009). Expedient synthesis of 3-hydroxyisoquinolines and 2-hydroxy-1,4-naphthoquinones via one-pot aryne acyl-alkylation/condensation. Organic & Biomolecular Chemistry. 7(23). 4960–4960. 61 indexed citations
8.
Allan, Kevin M. & Brian M. Stoltz. (2009). Synthesis of (-)-Quinocarcin. Synfacts. 2009(7). 708–708. 1 indexed citations
9.
Allan, Kevin M. & Brian M. Stoltz. (2008). A Concise Total Synthesis of (−)-Quinocarcin via Aryne Annulation. Journal of the American Chemical Society. 130(51). 17270–17271. 88 indexed citations
10.
Gilmore, Christopher D., Kevin M. Allan, & Brian M. Stoltz. (2008). Orthogonal Synthesis of Indolines and Isoquinolines via Aryne Annulation. Journal of the American Chemical Society. 130(5). 1558–1559. 207 indexed citations
11.
Gilmore, Christopher D., Kevin M. Allan, & Brian M. Stoltz. (2008). ChemInform Abstract: Orthogonal Synthesis of Indolines and Isoquinolines via Aryne Annulation.. ChemInform. 39(22). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026